D-0403-2026 Class II Ongoing

Recalled by MACLEODS PHARMA USA, INC — Princeton, NJ

FDA drug recall D-0403-2026 was initiated by MACLEODS PHARMA USA, INC on Feb 26, 2026 and is designated Class II. Reason for recall: Subpotent Drug The recall status is ongoing. Affected quantity: 1315 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 1, 2026
Initiation Date
Feb 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1315 bottles

Product description

Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44

Reason for recall

Subpotent Drug

Distribution pattern

Nationwide

Code information

Lot 16240062A, exp date 3/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0403-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0403-2026. Report a data issue: hello@regdatalab.com.